Company Filing History:
Years Active: 2025
Title: David J Elzi: Innovator in Cancer Treatment
Introduction
David J Elzi is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on utilizing RNA interference (RNAi) technology to create effective therapeutic agents.
Latest Patents
David J Elzi holds a patent for "Compositions and methods for treating cancer." This patent describes a double-stranded RNA interference (RNAi) agent that includes at least one of the following: a first double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a CD320 gene, a second dsRNA for inhibiting the expression of a LRP2 gene, or a cocktail of both. The patent emphasizes the use of these RNAi agents as pharmaceutical compositions for treating cancer in subjects in need of treatment. He has 1 patent to his name.
Career Highlights
David J Elzi is currently associated with Bioaffinity Technologies, Inc., where he continues to advance his research in cancer therapies. His work is characterized by a commitment to developing innovative solutions that can significantly impact patient care.
Collaborations
David collaborates with esteemed colleagues, including William E Bauta and Vivienne I Rebel. Their combined expertise fosters a productive environment for groundbreaking research and development.
Conclusion
David J Elzi is a prominent figure in the field of cancer treatment, with a focus on RNA interference technology. His contributions through patents and collaborations highlight his dedication to improving therapeutic options for patients.